Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. | Biomolecules | 2021 | 34439774 | PubTator, text mining | PubMed |
| Modulation of Cancer Cell Autophagic Responses by Graphene-Based Nanomaterials: Molecular Mechanisms and Therapeutic Implications. | Cancers (Basel) | 2021 | 34439299 | PubTator, text mining | PubMed |
| Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1. | Cancers (Basel) | 2021 | 34439235 | PubTator, text mining | PubMed |
| Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer. | Cancers (Basel) | 2021 | 34439137 | PubTator, text mining | PubMed |
| p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells. | Front Immunol | 2021 | 34434190 | PubTator, text mining | PubMed |
| Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR. | J Biol Chem | 2021 | 34418432 | PubTator, text mining | PubMed |
| Human cytomegalovirus blocks canonical TGFβ signaling during lytic infection to limit induction of type I interferons. | PLoS Pathog | 2021 | 34411201 | PubTator, text mining | PubMed |
| Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma. | BMC Cancer | 2021 | 34407796 | PubTator, text mining | PubMed |
| EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity. | PLoS Pathog | 2021 | 34407150 | PubTator, text mining | PubMed |
| Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer. | BMC Cancer | 2021 | 34399719 | PubTator, text mining | PubMed |
| Effects of infections on the pathogenesis of cancer. | Indian J Med Res | 2021 | 34380789 | PubTator, text mining | PubMed |
| DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis. | Acta Naturae | 2021 | 34377555 | PubTator, text mining | PubMed |
| Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. | Theranostics | 2021 | 34373744 | PubTator, text mining | PubMed |
| BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters. | EMBO Rep | 2021 | 34369648 | PubTator, text mining | PubMed |
| Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters. | Front Immunol | 2021 | 34367148 | PubTator, text mining | PubMed |
| The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation. | Virol J | 2021 | 34362398 | PubTator, text mining | PubMed |
| Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach. | Int J Mol Sci | 2021 | 34360800 | PubTator, text mining | PubMed |
| Impact of Hypoxia over Human Viral Infections and Key Cellular Processes. | Int J Mol Sci | 2021 | 34360716 | PubTator, text mining | PubMed |
| Immunometabolism Modulation in Therapy. | Biomedicines | 2021 | 34356862 | PubTator, text mining | PubMed |
| Development of a Lateral Flow Immunoassay (LFIA) to Screen for the Release of the Endocrine Disruptor Bisphenol A from Polymer Materials and Products. | Biosensors (Basel) | 2021 | 34356704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=43